Qube Research & Technologies (QRT)’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History
Bought
Maintained
Sold
Other funds holding GNOM
OAM
AAP
SWP
CFD
FIA
Qube Research & Technologies (QRT)'s GNOM Position: Q2 2026 in Review
Qube Research & Technologies (QRT) reduced its Global X Genomics & Biotechnology ETF (GNOM) stake by 87% in Q2 2026, selling an estimated $10.7K and leaving 34 shares worth $1.93K. The position accounts for ﹤0.01% of the portfolio, ranked #3368.
Qube Research & Technologies (QRT) first reported a position in GNOM in Q4 2021 and has held it in 19 quarters since. The position peaked at $282K in Q2 2023. 48 funds tracked by Wall St. Rank hold GNOM as of Q2 2026.
- Qube Research & Technologies (QRT) held 34 shares of Global X Genomics & Biotechnology ETF worth $1.93K as of Q2 2026.
- Qube Research & Technologies (QRT) sold 224 Global X Genomics & Biotechnology ETF shares in Q2 2026, an estimated $10.7K.
- Global X Genomics & Biotechnology ETF made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #3368 holding.
- Qube Research & Technologies (QRT) first reported a position in Global X Genomics & Biotechnology ETF in Q4 2021 and has held it in 19 quarters since.
- Qube Research & Technologies (QRT)'s Global X Genomics & Biotechnology ETF position peaked at $282K in Q2 2023.
- 48 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2026.
Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.